Keywords: Cancer; Ovarian; Neurofibromatosis; NF1;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: OPG; optic pathway glioma; NF1; neurofibromatosis type 1; SEER Program; surveillance, epidemiology, and end results; US; United States; IR; incidence rate; IRR; age-adjusted incidence rate ratio; CIs; confidence intervals; OR; odds ratio; Optic pathway gl
Keywords: DCP; deep capillary plexus; ETDRS; Early Treatment Diabetic Retinopathy Study; FAZ; foveal avascular zone; GCC; ganglion cell complex; INL; inner nuclear layer; MRI; magnetic resonance imaging; NF1; neurofibromatosis type 1; OCTA; OCT angiography; OPG; op
Keywords: Extracranial vertebral artery; Hybrid operating room; Primary aneurysm; Revascularization; NF1; Neurofibromatosis type 1; VA; Vertebral artery;
Keywords: ASIP; Agouti signalling protein; BMDC; bone marrow-derived cell; ERK; extracellular signal-regulated kinase; GPCR; G protein-coupled receptor; HBD3; human β-defensin 3; KITLG; KIT ligand; LN; lymph node; MC; melanoma cell; MC1R; melanocortin 1 receptor;
Keywords: Peripheral neuropathy; NF1; NF2; Schwannomatosis; Schwannoma; Neurofibroma; Nerve microlesions;
Keywords: ACSVL3; acyl-coA synthetase VL3; ALDH1; aldehyde dehydrogenase; ALDOA; aldolase A; ALDOC; aldolase C; AMPK; 5â² AMP-activated protein kinase; ASNS; asparagine synthetase; BTICs; brain tumor initiating cells; 3-BrOP; 3-bromo-2-oxopropionate-1-propyl ester
Keywords: Lipid; Metabolism; Myopathy; Diet; ABHD5; α/β-Hydrolase Domain-5; AC; adenylate cyclase; anti-ACVR2B; mouse monoclonal activin receptor type IIB; ATGL; adipose triglyceride lipase; BEZ; bezafibrate; CACT; carnitine translocase; CD36; cluster of differen
Keywords: NF1; Neurofibromatosis type 1; MTS; Mesial Temporal Sclerosis; FCD; Focal Cortical Dysplasia; mTOR; Mechanistic Target Of Rapamycin; GTC; Generalized Tonic-Clonic; NBO; Neurofibromatosis Bright Objects; Neurofibromatosis type 1; Mesial temporal sclerosis;
Keywords: NF1; BOLD; Pediatric; Brain training; Working memory; Regional homogeneity; Fractional amplitude of low frequency fluctuations;
Keywords: Moyamoya; Neurofibromatosis 1; Revascularization; Stroke; ICA; Internal carotid artery; IRB; Institutional Review Board; MMS; Moyamoya syndrome; mRS; Modified Rankin Scale; NF1; Neurofibromatosis 1; TIA; Transient ischemic attack;
Keywords: EGFR; Epidermal growth factor receptor; TP53; Tumor protein p53; KRAS; Kirsten rat carcoma viral oncogene; ALK; Anaplastic lymphoma kinase; RTK; Protein receptor tyrosine kinase; TKI; Tyrosine kinase inhibitor; PI3K; Phosphatidylinositol 3-kinase; NSCLC;
Keywords: corpus callosum; agenesis of corpus callosum; dysgenesis of corpus callosum; CNV; SNP array; chromosomal microarray; CNVs; Copy number variations; DGV; Database of genomic variants; NF1; Neurofibromatosis type 1; SHH; Sonic hedgehog; VOUS; Variants of unk
Keywords: FDA; Food and Drug Administration; MEK; mitogen-activated protein kinase kinase; MRI; magnetic resonance imaging; NF1; neurofibromatosis type 1; OPPN; orbital-periorbital plexiform neurofibroma; PN; plexiform neurofibroma; TTP; time to progression;
Keywords: genetics; MEN2; NF1; paraganglioma; pheochromocytoma; SDHB; SDHC; SDHD; tumour syndrome; VHL;
Keywords: BD; bipolar disorder; CSF; cerebrospinal fluid; BDNF; brain-derived neurotrophic factor; NT3; neurotrophin-3; NT4; neurotrophin-4; NGF; nerve growth factor; Trk; tyrosine kinase receptor; p75; TNF receptor superfamily member 1B; CNS; central nervous syste
Keywords: Neuroendocrine tumor; Islet cell tumor; Insulinoma; Gastrinoma; MEN1; VHL; TSC; NF1;
Keywords: fMRI; NF1; Working memory; Spatial ability; Psychophysiological interaction;
Keywords: NF1; Neurofibromatosis Type 1; NPRI; NF1 Patient Registry Initiative; OPG; optic pathway glioma; PBT; pediatric brain tumor; Neurofibromatosis 1; Glioma; Brain neoplasms; Birth weight;
Keywords: Spinal fusion; Peripheral nerve sheath tumor; Outcomes; Complications; CPT; Current procedural terminology; FSNF; Familial spinal neurofibromatosis; GTR; Gross total resection; MPNST; Malignant peripheral nerve sheath tumor; NF1; Neurofibromatosis 1; NF2;
Keywords: neurofibromatosis type 1; reading deficit; phonics training; phonological awareness; intervention; ADHD; Attention deficit-hyperactivity disorder; CC2; Castles and Coltheart 2; FISIQ; Full-scale IQ; NF1; Neurofibromatosis type 1; SES; Socioeconomic status
Keywords: EEL; external elastic lamina; IEL; internal elastic lamina; I/M ratio; intima/media ratio; MNC; peripheral blood mononuclear cells; NF1; neurofibromatosis type 1; Nf1+/-; heterozygous for the Nf1 allele; Nf1+/-;p47-/-; heterozygous for the Nf1 allele an
Keywords: Neurofibroma; Atypical neurofibroma; Malignant peripheral nerve sheath tumor; Neurofibromatosis; NF1;
Keywords: CAPRI; Ca2+-promoted RAS inactivator; CRMP-2; collapsin response mediator protein-2; CSRD; cysteine/serine-rich domain; CTD; C-terminal domain; ERK; extracellular signal-regulated kinase; FTI; farnesyltransferase inhibitor; FAK1; focal adhesion kinase 1;
Keywords: AKT; protein kinase B; ATF4; activating transcription factor 4; cAMP; cyclic adenosine monophosphate; CCL5; (C-C motif) ligand 5; CNS; central nervous system; 4EBP1; 4E (elF4E) binding protein; ECM; extracellular matrix; ERK; p44/p42 extracellular signal-
Keywords: AAL; automated anatomical labeling; CNS; central nervous system; FDG; F-18-fluorodeoxyglucose; GABA; gamma-butyric acid; NF1; neurofibromatosis type 1; NPT; neuropsychological testing; PET; positron emission tomography; PNST; peripheral nerve sheet tumors
Keywords: CCHMC; Cincinnati Children's Hospital Medical Center; CNS; Central nervous system; MRI; Magnetic resonance imaging; NF; Neurofibromatosis; NF1; Neurofibromatosis type 1; OPG; Optic pathway glioma;
Keywords: TMS; NF1; Motor Learning; SICI
Keywords: PGD; NF1; fertility; pregnancy; in vitro fertilization; genetic counseling;
Keywords: CIDER; Clinical Investigation Data Exploration Repository; NF; Neurofibromatosis; NF1; Neurofibromatosis type 1; NPRI; NF1 Patient Registry Initiative; OPG; Optic pathway glioma;
Keywords: Colon Cancer; Functional Tests; Predisposition; Tumor; 6-TG; 6-thioguanine; CMMRD; constitutional mismatch repair; evMSI; ex vivo microsatellite instability; FAP; familial adenomatous polyposis; gMSI; germline microsatellite instability; IHC; immunohisto
Keywords: Neurofibromatosis; NF1; Internal jugular vein aneurysm; Fatal hemorrhage; Venous aneurysm;
Keywords: CS; Costello syndrome; NS; Noonan syndrome; CFCS; cardiofaciocutaneous syndrome; NF1; neurofibromatosis type 1; DXA; dual-energy X-ray absorptiometry; BMD; bone mineral density; S-BMD; subtotal bone mineral density; WBLH; whole body less head; L-BMD; lumb
Keywords: Diagnostic criteria; Neurocutaneous disease; Neurofibromatosis 1; NF1; Rare disease
Keywords: Pheochromocytoma; Paraganglioma; VHL; MEN2; NF1; SDHA;
Keywords: BASC-II; Behavior Assessment System for Children, Second Edition; BRIEF-P; Behavior Rating Inventory of Executive Function, Preschool Version; EOWPVT; Expressive One-Word Picture Vocabulary Test; NEPSY; Developmental Neuropsychological Assessment; NF1; Ne
Clinical findings and mutation analysis of NF1 patients in Turkey
Keywords: NF1; neurofibromatosis type 1; GTPase; Ras guanosine triphosphatase; NIH; National Institutes of Health; SSCP; single strand conformation polymorphism; HRM; High Resolution Melting Curve; CLS; café-au-lait spots; CN; cutaneous neurofibromas; LN; lisch no
Piebaldism with multiple café-au-lait-like hyperpigmented macules and inguinal freckling caused by a novel KIT mutation
Keywords: CALM; café-au-lait macules; NF1; neurofibromatosis type 1; TK; tyrosine kinase;
Human stem cell modeling in neurofibromatosis type 1 (NF1)
Keywords: NF1; Neurodevelopment; Neurofibroma; iPSC; Stem cell; Optic pathway glioma; Retinal ganglion cell; Microglia; Tumor;
Phenotypic expression of a spectrum of Neurofibromatosis Type 1 (NF1) mutations identified through NGS and MLPA
Keywords: NF1; Café-au-lait macules; Neurofibromas; Next generation sequencing; Disease causing variants; Genotyping;
Impaired Neuronal Differentiation of Neural Stem Cells Lacking the Engrailed-2 Gene
Keywords: ANOVA; analysis of variance; ASD; autism spectrum disorders; BDNF; brain-derived neurotrophic factor; d; days in vitro; E; embryonic day; En; engrailed; EthD-1; ethidium homodimer-1; FMRP; Fragile-X mental retardation protein; GABA; γ-aminobutyric acid;
ERK1/2 inhibitors: New weapons to inhibit the RAS-regulated RAF-MEK1/2-ERK1/2 pathway
Keywords: Akt; oncogene in the transforming retrovirus, AKT8; AP-1; activator protein 1; ARAF; v-raf murine sarcoma 3611 viral oncogene homologue; ASK1; apoptosis signal-regulating kinase 1; BCL2; B-cell lymphoma 2; BCL-XL; B-cell lymphoma extra large; BRAF; v-raf
Pharmacological inhibition of Anaplastic Lymphoma Kinase rescues spatial memory impairments in Neurofibromatosis 1 mutant mice
Keywords: Water maze; Spatial memory; Swim speed; Alk inhibitor; Neurofibromatosis; NF1;
Original ArticleClinical Presentation and Outcome of Patients With Optic Pathway Glioma
Keywords: NF1; neurofibromatosis; optic pathway glioma; pilocytic astrocytoma; pediatric tumor; clinical presentation; optic nerve glioma;
Mini-reviewThe role of the NORE1A tumor suppressor in Oncogene-Induced Senescence
Keywords: RASSF; HIPK2; PP1A; Retinoblastoma; p53; Ras; OIS; Oncogene-Induced Senescence; NORE1A; Novel Ras Effector 1A; Rb; Retinoblastoma Protein; PTM; Post-Translational Modification; EGFR; Epidermal Growth Factor Receptor; NF1; Neurofibromin 1; DAB2IP; DAB2 Int
Research reportGenetic inhibition of Anaplastic Lymphoma Kinase rescues cognitive impairments in Neurofibromatosis 1 mutant mice
Keywords: Alk; NF1; Hippocampus; Cognition; Neurofibromatosis;
Phenformin Enhances the Efficacy of ERK Inhibition in NF1-Mutant Melanoma
Keywords: AMPK; AMP-activated kinase; BRAFi; BRAF inhibitor; ERK; extracellular signal-regulated kinase; ERKi; ERK inhibitor; PGC1α; peroxisome proliferator-activated receptor gamma, coactivator 1-α; MEK; MAPK/ERK kinase; MEKi; MEK inhibitor; mTOR; mechanistic ta
Original ArticleClinical Value of Multiparametric Whole-Body Magnetic Resonance Imaging over Whole-Spine Magnetic Resonance Imaging in Patients with Neurofibromatosis Type I
Keywords: DWI; Neurofibromatosis; Tumor burden; Whole-body MRI; Whole-spine MRI; ADC; Apparent diffusion coefficient; ICC; Intraclass correlation; MPNST; Malignant peripheral nerve sheath tumor; MRI; Magnetic resonance imaging; NF1; Neurofibromatosis type 1; SD; St
Predicting neurofibromatosis type 1 risk among children with isolated café-au-lait macules
Keywords: algorithm; café-au-lait macules; neurofibromatosis type 1; prediction; AUC; area under the curve; CALM; café-au-lait macule; CI; confidence interval; NF1; neurofibromatosis type 1; NIH; National Institutes of Health;
Neurofibromatosis as a gateway to better treatment for a variety of malignancies
Keywords: NF; neurofibromatoses; NF1; neurofibromatosis type 1; NF2; neurofibromatosis type 2; WHO; World Health Organization; PN; plexiform neurofibromas; MPNST; malignant peripheral nerve sheath tumors; FTase; farnesyl transferase; TTP; time-to-progression; OPG;